A Machine Learning Model Accurately Predicts Ulcerative Colitis Activity at One Year in Patients Treated with Anti-Tumour Necrosis Factor α Agents

Background and objectives: The biological treatment is a promising therapeutic option for ulcerative colitis (UC) patients, being able to induce subclinical and long-term remission. However, the relatively high costs and the potential toxicity have led to intense debates over the most appropriate cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Popa, Iolanda Valentina, Burlacu, Alexandru, Mihai, Catalina, Prelipcean, Cristina Cijevschi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699478/
https://www.ncbi.nlm.nih.gov/pubmed/33233514
http://dx.doi.org/10.3390/medicina56110628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699478/
https://www.ncbi.nlm.nih.gov/pubmed/33233514
http://dx.doi.org/10.3390/medicina56110628

Ejemplares similares